Cancer along with cardiovascular disease are the main causes of death in the industrialised
countries around the World. Conventional cancer treatments are losing their therapeutic …

Peptide therapy has started since 1920s with the advent of insulin application, and now it
has emerged as a new approach in treatment of diseases including cancer. Using anti …

Four cardiac hormones, namely atrial natriuretic peptide, vessel dilator, kaliuretic peptide,
and long-acting natriuretic peptide, reduce up to 97% of all cancer cells in vitro. These four …

Epithelial sodium channels (ENaCs) located at the apical membrane of polarized epithelial
cells are regulated by the second messenger guanosine 3′, 5′-cyclic monophosphate …

Simple Summary Triple-negative breast cancer is a highly aggressive type of invasive breast
cancer in which the patients frequently develop resistance to inhibitors used for induction of …

Colorectal cancer (CRC) is a major health concern worldwide, as it is the third most
frequently diagnosed cancer and the second leading cause of cancer-related death. There …

The connection between heart failure (HF) and cancer through multiple pathways such as
inflammation, oxidative stress, and neurohormonal activation, among others, is well …

The C-type natriuretic peptide receptor (NPRC) is expressed in many cell types and binds all
natriuretic peptides with high affinity. Ligand binding results in the activation or inhibition of …

Background Four cardiovascular hormones, ie, vessel dilator, long-acting natriuretic peptide,
kaliuretic peptide, and atrial natriuretic peptide each at 1 mmol/L, decrease up to 97% of …

Background c‐F os is a cellular proto‐oncogene which dimerizes with c‐J un proto‐
oncogene to form AP‐1 transcription factor, which upregulates transcription of genes …